ArticleThe Journal of pharmacology and experimental therapeutics2012

Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.

Eric J Tarcha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.